Koyfin Home > Directory > Health Care > Intercept Pharmaceuticals > Cash Flow from Operations

Intercept Pharmaceuticals Cash Flow from Operations Chart (ICPT)

Intercept Pharmaceuticals annual/quarterly Cash Flow from Operations from 2011 to 2020. Cash flow from operating activities (CFO) is an accounting item that indicates the amount of money a company brings in from ongoing, regular business activities, such as manufacturing and selling goods or providing a service. Cash flow from operating activities does not include long-term capital or investment costs.
  • Intercept Pharmaceuticals Cash Flow from Operations for the quarter ending June 06, 2020 was $-15m a -215.02% increase of 32m year over year
  • Intercept Pharmaceuticals Cash Flow from Operations for the last 12 months ending June 06, 2020 was $-221m a -3.68% increase of 8m year over year
  • Intercept Pharmaceuticals Annual Cash Flow from Operations for 2019 was $-237m a -1.73% increase of 4m from 2018
  • Intercept Pharmaceuticals Annual Cash Flow from Operations for 2018 was $-241m a -10.26% increase of 25m from 2017
  • Intercept Pharmaceuticals Annual Cash Flow from Operations for 2017 was $-265m a -29.03% increase of 77m from 2016
Other Cash Flow Metrics:
  • Intercept Pharmaceuticals Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-25m a -40.86% increase of 10m year over year
  • Intercept Pharmaceuticals Total Revenue for the quarter ending September 09, 2018 was $47m a 19.79% increase of 9m year over year
View Chart On Koyfin

Quarterly ICPT Cash Flow from Operations Data

06/2020$-15m
03/2020$-99m
12/2019$-60m
09/2019$-47m
06/2019$-46m
03/2019$-83m
12/2018$-53m
09/2018$-52m
06/2018$-47m
03/2018$-89m

Annual ICPT Cash Flow from Operations Data

2019$-237m
2018$-241m
2017$-265m
2016$-342m
2015$-163m
2014$-88m
2013$-28m
2012$-16m
2011$3m
2010$-14m